Paid Clinical Trials Shreveport

Discover 164 paid clinical trials in Shreveport, Louisiana. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 164

Steroids & TKIsTesting the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults

Recruiting

PHASE3

Sponsor:

National Cancer Institute (NCI)

Location:

Shreveport LA, Dallas TX, Fort Smith AR, Houston TXshow 142 more

Code:

NCT04530565

Conditions

B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Blinatumomab

Bone Marrow Aspiration and Biopsy

Cyclophosphamide

Cytarabine

Sacituzumab Tirumotecan & PembrolizumabSacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

Recruiting

PHASE3

Sponsor:

Merck Sharp & Dohme LLC

Location:

Shreveport LA, Tyler TX, Monroe LA, Tulsa OKshow 35 more

Code:

NCT06393374

Conditions

Triple-Negative Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Pembrolizumab

Sacituzumab tirumotecan

Capecitabine

BupropionBupropion to Reduce Cancer Related Fatigue in Cancer Survivors

Recruiting

PHASE3

Sponsor:

University of Rochester NCORP Research Base

Location:

Shreveport LA, Fort Smith AR, Baton Rouge LA, Covington LAshow 290 more

Code:

NCT03996265

Conditions

Be Diagnosed With Cancer and Have Completed Systemic Therapy

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Bupropion Hydrochloride Controlled-release

Placebo Administration

Quality-of-Life Assessment

Questionnaire Administration

Zanubrutinib & Anti-CD20A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma

Recruiting

PHASE3

Sponsor:

BeiGene

Location:

Shreveport LA, Longview TX, Tyler TX, Palestine TXshow 58 more

Code:

NCT05100862

Conditions

Relapsed/Refractory Follicular Lymphoma

Marginal Zone Lymphoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Zanubrutinib

Rituximab

Lenalidomide

Obinutuzumab

Observational StudyInterbody Systems: Post Market Clinical Follow-up Study

Recruiting

Sponsor:

K2M, Inc.

Location:

Shreveport LA, Oklahoma City OK

Code:

NCT04911257

Conditions

Degenerative Disc Disease

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Cervical or Lumbar Spinal fusion

SurvodutideLIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

Recruiting

PHASE3

Sponsor:

Boehringer Ingelheim

Location:

Shreveport LA, Monroe LA, Garland TX, Dallas TXshow 69 more

Code:

NCT06632457

Conditions

Metabolic Dysfunction Associated Steatohepatitis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Survodutide

Placebo matching survodutide

ResmetiromA Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES)

Recruiting

PHASE3

Sponsor:

Madrigal Pharmaceuticals, Inc.

Location:

Shreveport LA, Bastrop LA, Little Rock AR, North Little Rock ARshow 45 more

Code:

NCT05500222

Conditions

NASH

Cirrhosis, Liver

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Resmetirom

Placebo

CariprazineA Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.

Recruiting

PHASE3

Sponsor:

AbbVie

Location:

Shreveport LA, Beaumont TX, Plano TX, Dallas TXshow 45 more

Code:

NCT04777357

Conditions

Depression

Bipolar I Disorder

Eligibility Criteria

Sex: All

Age: 10 - 17

Healthy Volunteers: Not accepted

Interventions

Cariprazine

Placebo

Immunotherapy with ChemotherapyTesting the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-Small Cell Lung Cancer, ALCHEMIST Trial

Recruiting

PHASE3

Sponsor:

National Cancer Institute (NCI)

Location:

Shreveport LA, Alexandria LA, Hot Springs AR, Richardson TXshow 740 more

Code:

NCT04267848

Conditions

Lung Non-Small Cell Carcinoma

Lung Non-Small Cell Squamous Carcinoma

Lung Non-Squamous Non-Small Cell Carcinoma

Stage II Lung Cancer AJCC v8

Stage IIIA Lung Cancer AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Carboplatin

Cisplatin

Computed Tomography

Echocardiography Test

Elagolix & ContraceptivesStudy Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules/Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain

Recruiting

PHASE3

Sponsor:

AbbVie

Location:

Shreveport LA, Eunice LA, Little Rock AR, Dallas TXshow 133 more

Code:

NCT04333576

Conditions

Endometriosis

Eligibility Criteria

Sex: Female

Age: 18 - 49

Healthy Volunteers: Not accepted

Interventions

Elagolix

Placebo

Combined Oral Contraceptive